Clinical Trial Update: Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial update on rasburicase for treating hyperuricemia in adults with acute lymphoblastic leukemia or high-grade lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Lymphoma
• Lymphocytic Leukemia

Drugs mentioned

• Rasburicase (rasburicase)

Snippet

Sponsor: Goethe University | Conditions: Adult Acute Lymphocytic Leukemia, High-grade Lymphoma | Phase 3 | Status: COMPLETED